Log in

NYSE:EVH - Evolent Health Stock Price, Forecast & News

$11.77
+0.13 (+1.12 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$11.40
Now: $11.77
$12.01
50-Day Range
$8.96
MA: $10.62
$11.77
52-Week Range
$5.50
Now: $11.77
$15.12
Volume1.27 million shs
Average Volume812,715 shs
Market Capitalization$995.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.09
Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Read More…

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
Phone571-389-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$627.06 million
Cash Flow$0.28 per share
Book Value$14.44 per share

Profitability

Net Income$-52,660,000.00

Miscellaneous

Employees3,800
Market Cap$995.86 million
Next Earnings Date2/25/2020 (Confirmed)
OptionableOptionable

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.


Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) posted its quarterly earnings data on Tuesday, November, 5th. The technology company reported ($0.09) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.12) by $0.03. The technology company had revenue of $220.14 million for the quarter, compared to analysts' expectations of $217.90 million. Evolent Health had a negative net margin of 15.02% and a negative return on equity of 6.93%. Evolent Health's revenue for the quarter was up 46.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.04) earnings per share. View Evolent Health's Earnings History.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Evolent Health.

How can I listen to Evolent Health's earnings call?

Evolent Health will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for EVH?

8 brokers have issued 1 year target prices for Evolent Health's shares. Their forecasts range from $10.00 to $19.00. On average, they anticipate Evolent Health's share price to reach $14.89 in the next twelve months. This suggests a possible upside of 26.5% from the stock's current price. View Analyst Price Targets for Evolent Health.

What is the consensus analysts' recommendation for Evolent Health?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

Has Evolent Health been receiving favorable news coverage?

Media coverage about EVH stock has trended very positive recently, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Evolent Health earned a daily sentiment score of 3.1 on InfoTrie's scale. They also gave news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Evolent Health.

Who are some of Evolent Health's key competitors?

What other stocks do shareholders of Evolent Health own?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
  • Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
  • Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
  • Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Credit Suisse AG (4.43%), Eagle Asset Management Inc. (4.03%), Riverbridge Partners LLC (3.42%), Sectoral Asset Management Inc (2.36%), Formula Growth Ltd. (2.26%) and Bank of New York Mellon Corp (1.90%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.

Which major investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., Bank of America Corp DE, Riverbridge Partners LLC, Royce & Associates LP, Peregrine Capital Management LLC, Rock Point Advisors LLC, Oppenheimer & Co. Inc. and White Pine Investment CO. View Insider Buying and Selling for Evolent Health.

Which major investors are buying Evolent Health stock?

EVH stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Point72 Asset Management L.P., California Public Employees Retirement System, Sectoral Asset Management Inc, Eagle Asset Management Inc., Formula Growth Ltd., Dean Capital Investments Management LLC and Credit Suisse AG. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet, Michael D'amato and Seth Blackley. View Insider Buying and Selling for Evolent Health.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $11.77.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $995.86 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.

What is Evolent Health's official website?

The official website for Evolent Health is http://www.evolenthealth.com/.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (NYSE EVH)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  467 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  747
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel